DepoMed, Inc. (DEPO) Tops Q1 EPS by 8c

DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of ($0.16), $0.08 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $12.88 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• Semtech (SMTC) Tops Q2 EPS by 10c, Beats on Revenue; Offers Q3 Guidance
• Strattec Security Corp (STRT) Tops Q4 EPS by 94c